Demonstrate Your Biomarker & Diagnostics Capabilities to Japan’s Pharmaceutical Leaders

As the Japanese pharmaceutical market continues to surge, this goldmine market is seeking innovative, intelligent diagnostics solutions to enable successful CDx co-development. From biomarker & IVD platforms to regulatory consultancy, digital pathology tools to clinical sample testing, your solutions are in demand amongst this audience of Japan’s decision-makers.

The Clinical Biomarkers & CDx Japan Summit is the only event dedicated to uniting international and local CDx leaders for unrivalled networking and learning. This is your opportunity to connect with global and domestic leaders, showcase your services, and keep your finger on the pulse of Japan’s unique CDx landscape.

Whether you’re looking to establish yourself as a reliable and trusted diagnostic partner within this rapidly growing market or you want to strengthen your position to establish yourself as Japan’s go-to provider, this forum is where pivotal partnerships are formed, which power the future of precision oncology.

19 (1)

What to Expect?

Position Yourself as the Go-To Diagnostics Leader

Demonstrate your omics, diagnostics, and biomarker expertise through data-driven presentations, scientific posters, or panel discussions

Connect with the Untapped Japanese Pharmaceutical Market

Build meaningful industry relationships with the thought leaders and decision makers driving precision medicine in Japan

Uncover Actionable Insights on Japan’s Unique CDx Strategy

Gain first-hand insight into evolving regulatory, reimbursement and commercialization priorities within Japan, direct from the experts

Elevate Your Brand and Form Powerful Industry Partnerships

Share your success stories, exemplify your customer service and forge industry-defining partnerships set to transform precision medicine both in Japan and internationally

Key Interest Areas

Our pharmaceutical and academic audience is looking for technologies and solutions in the following areas:

  • Biomarker platforms
  • Companion diagnostic development
  • Omics technologies
  • Digital athology
  • Imaging
  • Sample testing
  • Diagnostic labs
  • Flow cytometry
  • Regulatory support
9-2

Hear What Our Past Sponsors Have to Say

Riken Genesis - Testimonial the World CB & CDX Summit Japan

The ability to easily communicate with decision-makers and members in positions to influence decision-makers at various pharmaceutical companies, CDx providers, and CROs

Chief Executive Officer, Riken Genesis

ALMAC - Partner for the World CB & CDX Summit Japan

I found the attendees to be very friendly and approachable and there was a great sense of community

Vice President of Clinical Testing, Almac

Audience Composition

Company Type

Types of Companies Graph

Attendee Seniority

Seniority of Attendees Graph

Attending Companies Include

Available Inventory

We have a range of inventory from standard booth and speaking slots to more bespoke deliverables such as lanyards, exclusive dinners and tours to help elevate your brand.

Presenting Slots
Leading Innovation
Full Delegate List
Exhibition Booths
Networking
Bespoke Hosting
Champion the Industry
Branding Opporunities

Get in Touch

Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.

Sam Sarwar

Commercial Director - Biomarkers & Diagnostics
Clinical Biomarkers & CDx Japan Summit

Maintain Your Competitive Edge
Maintain Your Competitive Edge

Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma discussions.

Network with Decision Makers
Network With Decision-Makers

Speak with our audience of senior scientific experts during dedicated meeting breaks and structured networking opportunities.

Showcase your capabilities
Showcase Your Capabilities

Explore our bespoke sponsorship options including branding, presenting, and exhibiting to build a package tailored to you and your company's goals.